Biotie to Present at the upcoming Stifel 2015 Healthcare Conference
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. Press Release November 10, 2015 at 1.00
pm
Biotie to Present at the upcoming Stifel 2015 Healthcare Conference
TURKU, Finland, November November 10, 2015 - Biotie (Nasdaq Helsinki BTH1V;
NASDAQ: BITI) today announced that Timo Veromaa, President and Chief Executive
Officer, is scheduled to present at the Stifel 2015 Healthcare Conference to be
held at The New York Palace Hotel in New York on Tuesday November 17, 2015 at
15:45 Eastern Time.
A live audio webcast of the presentation will be available through the
http://www.biotie.com/investors/investor-calendar/2015.aspx?sc_lang=en pages of
Biotie's corporate website or at
http://www.veracast.com/webcasts/stifel/healthcare2015/21112408555.cfm Following
the live presentation, the webcast will be archived and available for replay at
the same address for a period of 30 days.
Turku, November 10, 2015
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Investor Relations Senior Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi(at)biotie.com
www.biotie.com
About Biotie
Biotie is a specialized drug development company focused on products for
neurodegenerative and psychiatric disorders. Biotie's development has delivered
Selincro (nalmefene) for alcohol dependence, which received European marketing
authorization in 2013 and is currently being rolled out across Europe by partner
Lundbeck. The current development products include tozadenant for Parkinson's
disease, which is in Phase 3 development, and two additional compounds which are
in Phase 2 development for cognitive disorders including Parkinson's disease
dementia, and primary sclerosing cholangitis (PSC), a rare fibrotic disease of
the liver.
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via GlobeNewswire
[HUG#1965710]
Unternehmensinformation / Kurzprofil:
Datum: 10.11.2015 - 12:00 Uhr
Sprache: Deutsch
News-ID 433439
Anzahl Zeichen: 2648
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 166 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biotie to Present at the upcoming Stifel 2015 Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
